Loss of neurosteroid-mediated protection following stress during fetal life

Jonathan J. Hirst, Angela L. Cumberland, Julia C. Shaw, Greer A. Bennett, Meredith A. Kelleher, David W. Walker, Hannah K. Palliser

Research output: Contribution to journalReview ArticleOtherpeer-review

10 Citations (Scopus)

Abstract

Elevated levels of neurosteroids during late gestation protect the fetal brain from hypoxia/ischaemia and promote neurodevelopment. Suppression of allopregnanolone production during pregnancy leads to the onset of seizure-like activity and potentiates hypoxia-induced brain injury. Markers of myelination are reduced and astrocyte activation is increased. The placenta has a key role in maintaining allopregnanolone concentrations in the fetal circulation and brain during gestation and levels decline markedly after both normal and preterm birth. This leads to the preterm neonate developing in a neurosteroid deficient environment between delivery and term equivalence. The expression of 5α-reductases is also lower in the fetus prior to term. These deficiencies in neurosteroid exposure may contribute to the increase in incidence of the adverse patterns of behaviour seen in children that are born preterm. Repeated exposure to glucocorticoid stimulation suppresses 5α-reductase expression and allopregnanolone levels in the fetus and results in reduced myelination. Both fetal growth restriction and prenatal maternal stress lead to increased cortisol concentrations in the maternal and fetal circulation. Prenatal stress results in reduced expression of key GABAA receptor subunits that normally heighten neurosteroid sensitivity. These stressors also result in altered placental allopregnanolone metabolism pathways. These findings suggest that reduced neurosteroid production and action in the perinatal period may contribute to some of the adverse neurodevelopmental and behavioural outcomes that result from these pregnancy compromises. Studies examining perinatal steroid supplementation therapy with non-metabolisable neurosteroid analogues to improve these outcomes are warranted.

Original languageEnglish
Pages (from-to)181-188
Number of pages8
JournalJournal of Steroid Biochemistry and Molecular Biology
Volume160
DOIs
Publication statusPublished - 1 Jun 2016

Keywords

  • Allopregnanolone
  • Fetus
  • Neonate
  • Perinatal brain injury
  • Placenta
  • Pregnancy compromise
  • Preterm birth

Cite this

Hirst, J. J., Cumberland, A. L., Shaw, J. C., Bennett, G. A., Kelleher, M. A., Walker, D. W., & Palliser, H. K. (2016). Loss of neurosteroid-mediated protection following stress during fetal life. Journal of Steroid Biochemistry and Molecular Biology, 160, 181-188. https://doi.org/10.1016/j.jsbmb.2015.09.012
Hirst, Jonathan J. ; Cumberland, Angela L. ; Shaw, Julia C. ; Bennett, Greer A. ; Kelleher, Meredith A. ; Walker, David W. ; Palliser, Hannah K. / Loss of neurosteroid-mediated protection following stress during fetal life. In: Journal of Steroid Biochemistry and Molecular Biology. 2016 ; Vol. 160. pp. 181-188.
@article{11492984deaa491d911e747cb107ec1a,
title = "Loss of neurosteroid-mediated protection following stress during fetal life",
abstract = "Elevated levels of neurosteroids during late gestation protect the fetal brain from hypoxia/ischaemia and promote neurodevelopment. Suppression of allopregnanolone production during pregnancy leads to the onset of seizure-like activity and potentiates hypoxia-induced brain injury. Markers of myelination are reduced and astrocyte activation is increased. The placenta has a key role in maintaining allopregnanolone concentrations in the fetal circulation and brain during gestation and levels decline markedly after both normal and preterm birth. This leads to the preterm neonate developing in a neurosteroid deficient environment between delivery and term equivalence. The expression of 5α-reductases is also lower in the fetus prior to term. These deficiencies in neurosteroid exposure may contribute to the increase in incidence of the adverse patterns of behaviour seen in children that are born preterm. Repeated exposure to glucocorticoid stimulation suppresses 5α-reductase expression and allopregnanolone levels in the fetus and results in reduced myelination. Both fetal growth restriction and prenatal maternal stress lead to increased cortisol concentrations in the maternal and fetal circulation. Prenatal stress results in reduced expression of key GABAA receptor subunits that normally heighten neurosteroid sensitivity. These stressors also result in altered placental allopregnanolone metabolism pathways. These findings suggest that reduced neurosteroid production and action in the perinatal period may contribute to some of the adverse neurodevelopmental and behavioural outcomes that result from these pregnancy compromises. Studies examining perinatal steroid supplementation therapy with non-metabolisable neurosteroid analogues to improve these outcomes are warranted.",
keywords = "Allopregnanolone, Fetus, Neonate, Perinatal brain injury, Placenta, Pregnancy compromise, Preterm birth",
author = "Hirst, {Jonathan J.} and Cumberland, {Angela L.} and Shaw, {Julia C.} and Bennett, {Greer A.} and Kelleher, {Meredith A.} and Walker, {David W.} and Palliser, {Hannah K.}",
year = "2016",
month = "6",
day = "1",
doi = "10.1016/j.jsbmb.2015.09.012",
language = "English",
volume = "160",
pages = "181--188",
journal = "Journal of Steroid Biochemistry and Molecular Biology",
issn = "0960-0760",
publisher = "Elsevier",

}

Hirst, JJ, Cumberland, AL, Shaw, JC, Bennett, GA, Kelleher, MA, Walker, DW & Palliser, HK 2016, 'Loss of neurosteroid-mediated protection following stress during fetal life', Journal of Steroid Biochemistry and Molecular Biology, vol. 160, pp. 181-188. https://doi.org/10.1016/j.jsbmb.2015.09.012

Loss of neurosteroid-mediated protection following stress during fetal life. / Hirst, Jonathan J.; Cumberland, Angela L.; Shaw, Julia C.; Bennett, Greer A.; Kelleher, Meredith A.; Walker, David W.; Palliser, Hannah K.

In: Journal of Steroid Biochemistry and Molecular Biology, Vol. 160, 01.06.2016, p. 181-188.

Research output: Contribution to journalReview ArticleOtherpeer-review

TY - JOUR

T1 - Loss of neurosteroid-mediated protection following stress during fetal life

AU - Hirst, Jonathan J.

AU - Cumberland, Angela L.

AU - Shaw, Julia C.

AU - Bennett, Greer A.

AU - Kelleher, Meredith A.

AU - Walker, David W.

AU - Palliser, Hannah K.

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Elevated levels of neurosteroids during late gestation protect the fetal brain from hypoxia/ischaemia and promote neurodevelopment. Suppression of allopregnanolone production during pregnancy leads to the onset of seizure-like activity and potentiates hypoxia-induced brain injury. Markers of myelination are reduced and astrocyte activation is increased. The placenta has a key role in maintaining allopregnanolone concentrations in the fetal circulation and brain during gestation and levels decline markedly after both normal and preterm birth. This leads to the preterm neonate developing in a neurosteroid deficient environment between delivery and term equivalence. The expression of 5α-reductases is also lower in the fetus prior to term. These deficiencies in neurosteroid exposure may contribute to the increase in incidence of the adverse patterns of behaviour seen in children that are born preterm. Repeated exposure to glucocorticoid stimulation suppresses 5α-reductase expression and allopregnanolone levels in the fetus and results in reduced myelination. Both fetal growth restriction and prenatal maternal stress lead to increased cortisol concentrations in the maternal and fetal circulation. Prenatal stress results in reduced expression of key GABAA receptor subunits that normally heighten neurosteroid sensitivity. These stressors also result in altered placental allopregnanolone metabolism pathways. These findings suggest that reduced neurosteroid production and action in the perinatal period may contribute to some of the adverse neurodevelopmental and behavioural outcomes that result from these pregnancy compromises. Studies examining perinatal steroid supplementation therapy with non-metabolisable neurosteroid analogues to improve these outcomes are warranted.

AB - Elevated levels of neurosteroids during late gestation protect the fetal brain from hypoxia/ischaemia and promote neurodevelopment. Suppression of allopregnanolone production during pregnancy leads to the onset of seizure-like activity and potentiates hypoxia-induced brain injury. Markers of myelination are reduced and astrocyte activation is increased. The placenta has a key role in maintaining allopregnanolone concentrations in the fetal circulation and brain during gestation and levels decline markedly after both normal and preterm birth. This leads to the preterm neonate developing in a neurosteroid deficient environment between delivery and term equivalence. The expression of 5α-reductases is also lower in the fetus prior to term. These deficiencies in neurosteroid exposure may contribute to the increase in incidence of the adverse patterns of behaviour seen in children that are born preterm. Repeated exposure to glucocorticoid stimulation suppresses 5α-reductase expression and allopregnanolone levels in the fetus and results in reduced myelination. Both fetal growth restriction and prenatal maternal stress lead to increased cortisol concentrations in the maternal and fetal circulation. Prenatal stress results in reduced expression of key GABAA receptor subunits that normally heighten neurosteroid sensitivity. These stressors also result in altered placental allopregnanolone metabolism pathways. These findings suggest that reduced neurosteroid production and action in the perinatal period may contribute to some of the adverse neurodevelopmental and behavioural outcomes that result from these pregnancy compromises. Studies examining perinatal steroid supplementation therapy with non-metabolisable neurosteroid analogues to improve these outcomes are warranted.

KW - Allopregnanolone

KW - Fetus

KW - Neonate

KW - Perinatal brain injury

KW - Placenta

KW - Pregnancy compromise

KW - Preterm birth

UR - http://www.scopus.com/inward/record.url?scp=84966392093&partnerID=8YFLogxK

U2 - 10.1016/j.jsbmb.2015.09.012

DO - 10.1016/j.jsbmb.2015.09.012

M3 - Review Article

C2 - 26365557

AN - SCOPUS:84966392093

VL - 160

SP - 181

EP - 188

JO - Journal of Steroid Biochemistry and Molecular Biology

JF - Journal of Steroid Biochemistry and Molecular Biology

SN - 0960-0760

ER -